These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Immunosuppression. Binding by design. Ringe D Nature; 1991 May; 351(6323):185-6. PubMed ID: 1710317 [No Abstract] [Full Text] [Related]
5. Potential roles of other FK 506-binding proteins in mediating the effects of FK 506. Siekierka JJ; Wiederrecht G; Cryan J; Hung SH; Comisky M; Sigal NH Transplant Proc; 1991 Dec; 23(6):2720-1. PubMed ID: 1721256 [No Abstract] [Full Text] [Related]
6. Cyclophilin binding: a more accurate measure of cyclosporine immunosuppressive activity after renal transplantation. Paul K; Harding MW; Marks WH; Handschumacher RE; Lorber MI Transplant Proc; 1991 Feb; 23(1 Pt 2):974-5. PubMed ID: 1989349 [No Abstract] [Full Text] [Related]
7. Cyclosporine suppression of intracellular activation signal generation is not mediated by prolyl-peptidyl isomerase. Kimball PM; Kerman RH; Kahan BD Transplant Proc; 1991 Feb; 23(1 Pt 1):323-4. PubMed ID: 1990544 [No Abstract] [Full Text] [Related]
8. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action. Bierer BE Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531 [No Abstract] [Full Text] [Related]
10. Immunophilins, ligands, and the control of signal transduction. Schreiber SL; Crabtree GR Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988 [No Abstract] [Full Text] [Related]
11. Immunosuppression. Convergence of drug action. Freedman RB Nature; 1989 Oct; 341(6244):692. PubMed ID: 2477712 [No Abstract] [Full Text] [Related]
12. Biosynthesis and mechanism of action of cyclosporins. Lawen A Prog Med Chem; 1996; 33():53-97. PubMed ID: 8776941 [No Abstract] [Full Text] [Related]
13. Leukocyte chemotactic activity of FKBP and inhibition by FK506. Leiva MC; Lyttle CR Biochem Biophys Res Commun; 1992 Jul; 186(2):1178-83. PubMed ID: 1379802 [TBL] [Abstract][Full Text] [Related]
14. A natural specific intracellular ligand as a reagent for cyclosporine blood level determination. Hasková V; Rozprimová L; Svobodová J Folia Biol (Praha); 1991; 37(2):134-9. PubMed ID: 1874341 [TBL] [Abstract][Full Text] [Related]
15. Structure-function relationships in the FK506-binding protein (FKBP) family of peptidylprolyl cis-trans isomerases. Kay JE Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):361-85. PubMed ID: 8670043 [No Abstract] [Full Text] [Related]
16. Mechanism of action of FK 506 and cyclosporin. Steinmann B; Superti-Furga A; Bruckner P Lancet; 1991 Feb; 337(8738):439. PubMed ID: 1704088 [No Abstract] [Full Text] [Related]
17. FK-506 binding protein from Tolypocladium inflatum: resistance of FKBP/FK-506 complex against proteolysis. Lee C; Hoffmann K; Zocher R Biochem Biophys Res Commun; 1992 Feb; 182(3):1282-7. PubMed ID: 1371677 [TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of immunosuppression by cyclosporins. Zenke G; Baumann G; Wenger R; Hiestand P; Quesniaux V; Andersen E; Schreier MH Ann N Y Acad Sci; 1993 Jun; 685():330-5. PubMed ID: 7689806 [TBL] [Abstract][Full Text] [Related]
19. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Schreiber SL Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904 [TBL] [Abstract][Full Text] [Related]
20. Toward understanding the mechanism of ciclosporin (cyclosporine) immunosuppression. Lorber MI Year Immunol; 1988; 3():291-302. PubMed ID: 3327316 [No Abstract] [Full Text] [Related] [Next] [New Search]